Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

MARKER THERAPEUTICS, INC. (MRKR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

MARKER THERAPEUTICS, INC. (MRKR), most recent 12 months reported: revenue $3.55M, net loss $8.71M. Latest balance sheet on file: liquid cash $11.33M. From SEC filings. Others in Pharmaceutical Preparations: Ensysce Biosciences, Inc. · CAMP4 Therapeutics Corporation · CHINA PHARMA HOLDINGS, INC. · ProPhase Labs, Inc. · NRX Pharmaceuticals, Inc. · TherapeuticsMD, Inc. · XENETIC BIOSCIENCES, INC. · Polomar Health Services, Inc.

Stock screener

Watchlist